Filing Details

Accession Number:
0001209191-22-052717
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-05 16:05:26
Reporting Period:
2022-10-03
Accepted Time:
2022-10-05 16:05:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1654151 Deciphera Pharmaceuticals Inc. DCPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325710 L Matthew Sherman C/O Deciphera Pharmaceuticals, Inc.
200 Smith Street
Waltham MA 02451
Evp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-10-03 2,587 $18.73 74,297 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was to cover tax liabilities in the vesting of restricted stock.